Everything you need to know about GENE THERAPY for hemophilia A and B. First illustrated review describing basic principles, current evidence &clinical implementation by Cihan Ay et al published in @haemophilia journal It has been a wonderful experience curating the illustrations for the team. Art4Science (https://lnkd.in/e5eiWVtF) https://lnkd.in/eU2jv33N #genetherapy #haematology #hemophilia
Yuva Oz’s Post
More Relevant Posts
-
My thoughts on Cell & Gene Therapy Deveopment from a CMC and regulatory strategy perspective captured in a vlog by Darwin Shurig.
Interested in the current state of FDA approvals for cell and gene therapies, CMC-related challenges and the specifics of AAV-based gene therapy? Parexel Regulatory Strategy's, Rajiv Gangurde, Ph.D. discusses these topics and more in a two-part series with Shurig Solutions, Inc. Check out both episodes: https://lnkd.in/exx2NMQk https://lnkd.in/ej-3CWzW
Rajiv Gangurde part 1
share.parexel.social
To view or add a comment, sign in
-
🔍 Curious about the gene therapy landscape in 2023? 🌱 Explore part 2 of our 2023 Landscape Series for an in-depth analysis of trial updates in 2023, terminations and regulatory announcements. Download now! https://ter.li/2y5o6l #GeneTherapyInsights #2023Analysis #GeneTherapyInnovation #2023Review
To view or add a comment, sign in
-
-
Dive into hemophilia A gene therapy! 🧬 Learn who's eligible and what to expect from the latest clinical data. Enhance care with new insights on safety and efficacy. Register here: http://ms.spr.ly/6045Y8wch #HemophiliaATherapy 🩺💡
To view or add a comment, sign in
-
-
Overcome challenges like tedious revalidation and costly optimization during cell and gene therapy scale-up. With scalable technologies and flexible formats, we help you avoid problems with yield and process consistency, so you can meet increasing patient demand efficiently: https://sar.to/73hd8 #SimplifyingProgress #InThisTogether #AdvancedTherapies #CellandGeneTherapy
To view or add a comment, sign in
-
-
We’re sharing new data in #hemophiliaA at #ISTH2024, including four-year follow-up results from the longest and largest Phase 3 study of a gene therapy in #hemophilia. Read more here: https://bit.ly/3X9xKiN
To view or add a comment, sign in
-
Senior Marketing Automation Technical Specialist | Precision Medicine Enthusiast | Marketing Literature Reviewer
If you are curious about gene therapy, but don't know where to start, check out Biocompare's easy to read infographic about viral vectors: For non-PhDs, this field isn't easy to get started in, and this chart will help. https://lnkd.in/eH4SbFVr
To view or add a comment, sign in
-
When developing a gene therapy process, it can be hard to know where to start. Have no fear, our new filter selection guide is here to help. Download your free copy - https://cytiva.link/4snhx #mRNA #filtration
To view or add a comment, sign in
-
-
When developing a gene therapy process, it can be hard to know where to start. Have no fear, our new filter selection guide is here to help. Download your free copy - https://cytiva.link/4snhx #mRNA #filtration
To view or add a comment, sign in
-
-
When developing a gene therapy process, it can be hard to know where to start. Have no fear, our new filter selection guide is here to help. Download your free copy - https://cytiva.link/4snhx #mRNA #filtration
To view or add a comment, sign in
-
-
When developing a gene therapy process, it can be hard to know where to start. Have no fear, our new filter selection guide is here to help. Download your free copy - https://cytiva.link/4snhx #mRNA #filtration
To view or add a comment, sign in
-